Moran Wealth Management LLC Sells 33,693 Shares of Cigna Group $CI

Moran Wealth Management LLC trimmed its stake in Cigna Group (NYSE:CI) by 69.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,153 shares of the health services provider’s stock after selling 33,693 shares during the quarter. Moran Wealth Management LLC’s holdings in Cigna Group were worth $4,368,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Valeo Financial Advisors LLC increased its position in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares in the last quarter. Norges Bank acquired a new stake in Cigna Group in the second quarter valued at approximately $1,110,426,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. raised its position in shares of Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares during the period. Finally, Man Group plc lifted its holdings in shares of Cigna Group by 215.5% in the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock worth $175,929,000 after purchasing an additional 363,510 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of several research reports. Barclays upped their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “overweight” rating in a report on Monday. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Sunday, December 28th. Wolfe Research dropped their target price on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Finally, Robert W. Baird lowered their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $333.04.

Cigna Group Stock Up 1.7%

CI stock opened at $283.97 on Friday. The stock has a market cap of $75.86 billion, a P/E ratio of 12.53, a P/E/G ratio of 0.98 and a beta of 0.26. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $271.62 and its two-hundred day simple moving average is $289.39. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm earned $7.51 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. Cigna Group’s payout ratio is presently 26.64%.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani acquired 4,134 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.